Filing Details

Accession Number:
0001209191-14-033456
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-13 18:46:55
Reporting Period:
2014-05-09
Filing Date:
2014-05-13
Accepted Time:
2014-05-13 18:46:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283535 Gary Patou C/O Mpm Asset Management
601 Gateway Blvd., Suite 350
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-09 13,164 $1.61 13,164 No 4 M Direct
Common Stock Acquisiton 2014-05-09 6,836 $5.49 20,000 No 4 M Direct
Common Stock Disposition 2014-05-09 20,000 $74.08 0 No 4 S Direct
Common Stock Acquisiton 2014-05-12 10,000 $5.49 10,000 No 4 M Direct
Common Stock Disposition 2014-05-12 10,000 $75.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-05-09 13,164 $0.00 13,164 $1.61
Common Stock Stock Option (Right to Buy) Disposition 2014-05-09 6,836 $0.00 6,836 $5.49
Common Stock Stock Option (Right to Buy) Disposition 2014-05-12 10,000 $0.00 10,000 $5.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,920 2020-09-02 No 4 M Direct
35,532 2020-12-29 No 4 M Direct
25,532 2020-12-29 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 702 Indirect See footnote
Footnotes
  1. This transaction was pursuant to a 10b5-1 Plan dated March 11, 2014.
  2. Represents weighted average sales price. The shares were sold at prices ranging from $72.86 to $74.63. The Reporting Person will provide upon request, to the SEC, the Issuer or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Shares held by the Patou Family Trust, of which the reporting person is trustee.
  4. 25% of the option shares vested on September 2, 2011 and the remaining 75% of the option shares vest monthly over the next 36 months. The option shares become exercisable when vested.
  5. 25% of the option shares vested on December 29, 2011 and the remaining 75% of the option shares vest monthly over the next 36 months. The option shares become exercisable when vested.